<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045427"><TermName>tirapazamine</TermName><TermPronunciation>(TEER-uh-PA-zuh-meen)</TermPronunciation><TermDefinition><DefinitionText>A substance that has been studied in the treatment of some types of cancer. It may cause damage to the DNA in cells that have a low level of oxygen, including cancer cells. This may make the cells easier to kill with radiation therapy and chemotherapy. Tirapazamine  is a type of radiosensitizing agent and a type of chemosensitizing agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705450" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tirapazamine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705451" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tirapazamina&quot;" language="es" id="_4"/><SpanishTermName>tirapazamina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que se ha estudiado para el tratamiento de algunos tipos de cáncer. Puede producir daños en el ADN de las células que tienen concentraciones bajas de oxígeno, como las células cancerosas. Esto facilita la destrucción de las células con radioterapia y quimioterapia. La tirapazamina es un tipo de radiosensibilizador y un tipo de quimiosensibilizador.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2013-04-01</DateLastModified></GlossaryTerm>
